Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yoshihiro Miyahara
Observed names:
Y Miyahara,
Y. Miyahara,
YOSHIHIRO MIYAHARA
Institution:
Mie University
Observed institutions:
Memorial Sloan Kettering Cancer Center,
Okayama University,
Mie University,
Baylor College of Medicine,
Universität Ulm,
Washington University in St. Louis,
Ludwig Cancer Research,
Ludwig Cancer Research,
Nagasaki University,
University of Toledo
show all 10
ORCID:
0000-0002-6458-3167
Observed ORCID:
0000-0002-6458-3167
OpenAlex ID:
A5067458112
CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer
2007
·
Yukiko Kiniwa
, Yoshihiro Miyahara
, et al.
·
Clinical Cancer Research
·
362
Generation and regulation of human CD4 + IL-17-producing T cells in ovarian cancer
2008
·
Yoshihiro Miyahara
, Kunle Odunsi
, et al.
·
Proceedings of the National Academy of Sciences
·
286
Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer
2015
·
Shinichi Kageyama
, Hiroaki Ikeda
, et al.
·
Clinical Cancer Research
·
184
Safety and persistence of WT1-specific T-cell receptor gene−transduced lymphocytes in patients with AML and MDS
2017
·
Isao Tawara
, Shinichi Kageyama
, et al.
·
Blood
·
175
Toll-like receptors and immune regulation: implications for cancer therapy
2008
·
R-F Wang
, Y Miyahara
, et al.
·
Oncogene
·
151
Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistance
2019
·
Daisuke Muraoka
, Naohiro Seo
, et al.
·
Journal of Clinical Investigation
·
147
“Default” Generation of Neonatal Regulatory T Cells
2010
·
Guohua Wang
, Yoshihiro Miyahara
, et al.
·
The Journal of Immunology
·
144
Tumor-Associated Galectin-3 Modulates the Function of Tumor-Reactive T Cells
2008
·
Weiyi Peng
, Helen Y. Wang
, et al.
·
Cancer Research
·
138
PDF
HER2-Specific T-Cell Immune Responses in Patients Vaccinated with Truncated HER2 Protein Complexed with Nanogels of Cholesteryl Pullulan
2006
·
Shigehisa Kitano
, Shinichi Kageyama
, et al.
·
Clinical Cancer Research
·
133
Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients
2013
·
Shinichi Kageyama
, Hisashi Wada
, et al.
·
Journal of Translational Medicine
·
115
PDF
Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination
2018
·
Yasushi Akahori
, Linan Wang
, et al.
·
Blood
·
109
NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome
2022
·
Mikiya Ishihara
, Shigehisa Kitano
, et al.
·
Journal for ImmunoTherapy of Cancer
·
71
PDF
A novel role for Notch ligand Delta-1 as a regulator of human Langerhans cell development from blood monocytes
2005
·
Natsuki Hoshino
, Naoyuki Katayama
, et al.
·
Journal of Leukocyte Biology
·
71
Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity
2001
·
Hiroyoshi Nishikawa
, Koji Tanida
, et al.
·
Proceedings of the National Academy of Sciences
·
69
siRNA-mediated silencing of PD-1 ligands enhances tumor-specific human T-cell effector functions
2011
·
K Iwamura
, T Kato
, et al.
·
Gene Therapy
·
62
A phase 1 trial of NY‐ESO ‐1‐specific TCR ‐engineered T‐cell therapy combined with a lymph node‐targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma
2023
·
Mikiya Ishihara
, Yoshihiro Nishida
, et al.
·
International Journal of Cancer
·
61
PDF
MAGE-A4, NY-ESO-1 and SAGE mRNA expression rates and co-expression relationships in solid tumours
2020
·
Mikiya Ishihara
, Shinichi Kageyama
, et al.
·
BMC Cancer
·
58
PDF
Determination of Cellularly Processed HLA-A2402-Restricted Novel CTL Epitopes Derived from Two Cancer Germ Line Genes, MAGE-A4 and SAGE
2005
·
Yoshihiro Miyahara
, Hiroaki Naota
, et al.
·
Clinical Cancer Research
·
55
Intratumoral Injection of Propionibacterium acnes Suppresses Malignant Melanoma by Enhancing Th1 Immune Responses
2011
·
Kenshiro Tsuda
, Keiichi Yamanaka
, et al.
·
PLoS ONE
·
49
PDF
Safety and antibody immune response of CHP-NY-ESO-1 vaccine combined with poly-ICLC in advanced or recurrent esophageal cancer patients
2021
·
Takeshi Ishikawa
, Shinichi Kageyama
, et al.
·
Cancer Immunology Immunotherapy
·
43
First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors
2020
·
Mikiya Ishihara
, Yasutaka Tono
, et al.
·
Cancer Immunology Immunotherapy
·
39
PDF
Time-dependent transition of the immunoglobulin G subclass and immunoglobulin E response in cancer patients vaccinated with cholesteryl pullulan-melanoma antigen gene-A4 nanogel
2016
·
Noriaki Kyogoku
, Hiroaki Ikeda
, et al.
·
Oncology Letters
·
35
PDF
Safety and Efficacy of NY-ESO-1 Antigen-Specific T-Cell Receptor Gene-Transduced T Lymphocytes in Patients with Synovial Sarcoma: A Phase I/II Clinical Trial
2023
·
Akira Kawai
, Mikiya Ishihara
, et al.
·
Clinical Cancer Research
·
34
PDF
First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer
2019
·
Hiroyasu Oda
, Mikiya Ishihara
, et al.
·
Case Reports in Oncology
·
32
IL-2-deprivation and TGF-β are two non-redundant suppressor mechanisms of CD4+CD25+ regulatory T cell which jointly restrain CD4+CD25− cell activation
2010
·
Guohua Wang
, Mithun Khattar
, et al.
·
Immunology Letters
·
27
Show more works
View as search
Works count:
120
Citation count:
2,965
H-index:
25
I10-index:
36
Year
Topic
Type
